Search Results - "Pine, Polyn Luz"

Sex Disparity in the In-Hospital Outcomes of Patients with Kidney Disease Admitted for Myocardial Infarction: Insights from a Large National Database by Rivera, Frederick Berro, Ruyeras, Jade Monica Marie, Salva, Wailea Faye C, Balbin, Jeremiahdominic, Tang, Samantha, Pine, Polyn Luz S, Tangco, Gabriel A, Bantayan, Nathan Ross B, Amigo, John Andrew C, Ansay, Marie Francesca M, Matabang, Maria Angela, Lerma, Edgar V, Ong, Kenneth, Collado, Fareed Moses, Kazory, Amir

“…There is limited evidence as to the effect of sex on the outcomes of patients admitted for ST-elevation myocardial infarction (STEMI) who have a concomitant…”
Get full text

Abstract 4146295: Sex disparity in the in-hospital outcomes of patients with chronic kidney disease admitted for ST elevation myocardial infarction: Insights from a large national database by Rivera, Frederick, Ruyeras, Jade Monica Marie, Salva, Wailea Faye, Balbin, Jeremiahdominic, Tang, Samantha, Aparece, John Paul, Pine, Polyn Luz, Tangco, Gabriel, Bantayan, Nathan Ross, Amigo, John Andrew, Ansay, Marie Francesca, Matabang, Maria Angela, Lerma, Edgar, Ong, Kenneth, Collado, Fareed Moses, Kazory, Amir

“…Abstract only Background: Previous studies have highlighted the impact of sex differences on the outcomes of patients admitted for ST-elevation myocardial…”
Get full text

Evaluating the safety profile of semaglutide: an updated meta-analysis by Rivera, Frederick Berro, Arias-Aguirre, Eloise, Aguirre, Zedrick, Ybañez, Mc John C., Rubia, Janos Marc M., Galang, Danica Janine, Lumbang, Grace Nooriza, Ruyeras, Jade Monica Marie J., Magalong, John Vincent, Pine, Polyn Luz, Amigo, John Andrew C., Ansay, Marie Francesca M., Zelenkov, Nenad, Thomas, Steve Samuel, Vijayaraghavan, Krishnaswami

“…Semaglutide is increasingly used in the management of type 2 diabetes mellitus and obesity. Ensuring the safety of this medication is crucial for its clinical…”
Get full text

Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials by Rivera, Frederick Berro, Bantayan, Nathan Ross B., Aparece, John Paul, Cruz, Linnaeus Louisse A., Magallong, John Vincent, Pine, Polyn Luz, Idian-Javier, Anne Mira Nicca, Lumbang, Grace Nooriza O., Lerma, Edgar V., Lara-Breitinger, Kyla M., Gulati, Martha, Vijayaraghavan, Krishnaswami

“…•Women with type 2 diabetes and ethnic minorities remain underrepresented across multiple GLP-1RA cardiovascular outcome trials.•GLP-1 receptor agonists…”
Get full text

Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists by Rivera, Frederick Berro, Ybañez, Mc John Caro, Magalong, John Vincent, Prado, Mario, Aguirre, Eloise Arias, Cañares, Ana Patricia Ting, Rubia, Janos Marc, Hiyas, Allyn Ralph, Pine, Polyn Luz S., Lara-Breitinger, Kyla, Lopez-Jimenez, Francisco, Gulati, Martha

“…Randomized controlled trials (RCTs) of glucagon-like peptide 1 receptor agonists (GLP-1RAs) form the basis for therapeutic recommendations for both males and…”
Get full text

Impact of Chronic Kidney Disease on the Outcomes of Patients Undergoing Percutaneous Left Atrial Appendage Occlusion: Insights from a Large National Database by Rivera, Frederick Berro, Cha, Sung Whoy, Antia, Akanimo, Pine, Polyn Luz S., Tangco, Gabriel A., Lapid, Princess C., Jariyatamkitti, Sathika, Bantayan, Nathan Ross B., Salva, Wailea Faye C., Idian, Anne Mira Nicca, Lumbang, Grace Nooriza Opay, Layese, Charcel Lex, Lerma, Edgar V., Collado, Fareed Moses S., Volgman, Annabelle Santos, Kazory, Amir

“…Background: Studies exploring the effectiveness and safety of percutaneous left atrial appendage occlusion (pLAAO) in patients with chronic kidney disease…”
Get full text

Impact of Chronic Kidney Disease on the Outcomes of Patients Undergoing Left Atrial Appendage Occlusion: Insights from a Large National Database by Rivera, Frederick Berro, Cha, Sung Whoy, Antia, Akanimo, Pine, Polyn Luz S, Tangco, Gabriel A, Lapid, Princess C, Jariyatamkitti, Sathika, Bantayan, Nathan Ross B, Salva, Wailea Faye C, Idian, Anne Mira Nicca, Lumbang, Grace Nooriza Opay, Layese, Charcel Lex, Lerma, Edgar V, Collado, Fareed Moses S, Volgman, Annabelle Santos, Kazory, Amir

“…Studies exploring the effectiveness and safety of left atrial appendage occlusion (LAAO) in patients with chronic kidney disease (CKD) are limited. We utilized…”
Get full text

Evaluating the safety profile of semaglutide: an updated meta-analysis by Rivera, Frederick Berro, Arias-Aguirre, Eloise, Aguirre, Zedrick, Ybañez, Mc John C, Rubia, Janos Marc M, Galang, Danica Janine, Lumbang, Grace Nooriza, Ruyeras, Jade Monica Marie J, Magalong, John Vincent, Pine, Polyn Luz, Amigo, John Andrew C, Ansay, Marie Francesca M, Zelenkov, Nenad, Thomas, Steve Samuel, Vijayaraghavan, Krishnaswami

“…Semaglutide is increasingly used in the management of type 2 diabetes mellitus and obesity. Ensuring the safety of this medication is crucial for its clinical…”
Get full text